Wire Stories

Category Added in a WPeMatico Campaign

news_6

Sensorion Announces Approval in Australia to Initiate Proof of Concept Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation

Australian approval follows recent trial approval by regulatory authorities in France MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN), a...

Takeda_Red_Logo_2021

Takeda’s TAKHZYRO® (lanadelumab) Demonstrated Positive Results in the Prevention of HAE Attacks in First and Only Open-Label Phase 3 Trial in Children Ages 2 to <12 Years

Children Ages 2 to <12 Experienced 94.8% Fewer Hereditary Angioedema (HAE) Attacks During Treatment with TAKHZYRO Over the 52-Week Treatment...

Acumen-Research-and-Consulting-7

Growing Prevalence of Chronic and Undiagnosed Diseases Will Propel the Computer Aided Drug Discovery Market to Reach USD 7,232 Million By 2030 Report By Acumen Research and Consulting

Acumen Research and Consulting recently published report titled “Aided Drug Discovery Market Size, Share, Analysis Report and Region Forecast, 2022...